Monday, November 22, 2010

Preventing business if drug companies executives are convited of fraud

A recent article in the Washington Post states that federal investigators want to prevent drug companies with executives who have been involved in fraud from doing business with the US Government. The new guidelines were posted on October 20 on the office's webpage. This will help keep individuals accountable for their actions.

A few of the new sanctions include:
-Company executives might also be sanctioned if their employers are convicted of misconduct or they may be blocked from doing business with federal agencies.
-Misdemeanor convictions

What do you think about these new sanctions? Will it allow the government to keep their employees more honest?

No comments: